Skip to main content
Premium Trial:

Request an Annual Quote

Haplotypes Better than SNPs for Predicting Response to Cholesterol Drugs, Genaissance Researchers Find

NEW YORK, April 24-Researchers from Genaissance Pharmaceuticals have found that haplotypes are better than SNPs for predicting patient response to cholesterol-lowering drugs.


The finding is to be presented today at the American Heart Association Asia Pacific Scientific Forum.


In the study, researchers from Genaissance, Ruprecht Karls University, and Albert Ludwigs University identified 98 patients with high cholesterol. After initiating statin treatment, the researchers tracked changes in blood cholesterol and triglyceride levels. They also examined individual variations in the cholesteryl ester transfer protein (CETP) gene, which is thought to be involved in the balance between high- and low-density cholesterol levels, and tracked the activity of this gene during therapy.


The team found that while individual SNPS had little impact on gene expression or on drug efficacy, notable differences could be distinguished between patients with different haplotypes. For example, patients with two copies of one CETP haplotype showed a threefold increase in high-density cholesterol.


The effort is part of a larger Genaissance research project that is attempting to correlate patient genetic variations with the biological response to statin therapy. Genaissance hopes to develop markers that can guide clinicians in their drug-prescribing choices.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.